Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 6/20 | 0.46 |
| ▸ | MAPT | P10636 | 5/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | ERN1 | O75460 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.37 |
| ▸ | ACR | P10323 | 1/20 | 0.37 |
| ▸ | RARB | P10826 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22268363 | 0.98 | THRB (0.46) | THRBMAPTSMN1; SMN2ERN1HPGD | |
| SCHEMBL19497904 | 0.97 | THRB (0.45) | THRBMAPTSMN1; SMN2ERN1HPGD | |
| SCHEMBL23583588 | 0.94 | THRB (0.45) | THRBMAPTSMN1; SMN2ERN1PRSS1 | |
| SCHEMBL17933722 | 0.92 | THRB (0.45) | THRBMAPTSMN1; SMN2HPGDTSHR | |
| SCHEMBL19497860 | 0.90 | THRB (0.45) | THRBMAPTSMN1; SMN2HPGDTSHR | |
| SCHEMBL18200277 | 0.89 | THRB (0.44) | THRBMAPTSMN1; SMN2PRSS1ACR | |
| SCHEMBL19497896 | 0.88 | THRB (0.47) | THRBMAPTSMN1; SMN2RARBKMT2A | |
| SCHEMBL19352699 | 0.88 | HTT (0.40) | THRBMAPTSMN1; SMN2ERN1TSHR | |
| SCHEMBL19497950 | 0.86 | MAPT (0.46) | THRBMAPTSMN1; SMN2HPGDTSHR | |
| SCHEMBL19757183 | 0.86 | THRB (0.44) | THRBMAPTSMN1; SMN2ERN1PRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10723952-B2 | Polymerizable compound and optically anisotropic body | DIC CORPORATION (JP) | 2020-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10723952-B2 | Polymerizable compound and optically anisotropic body | SMC4, SMCHD1, PHOSPHO1 | THRB 4884/4885MAPT 17/4885SMN1; SMN2 1468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.